Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review

Journal of Clinical Medicine

Emad Salawati¹  Vincent Goëb²  Patrice Fardellone²  Laure Le Monnier² 

[1] Assistant Professor, Faculty of Medicine, King Abdulaziz University, 21589 Jeddah, Saudi Arabia;Department of Rheumatology, Picardie-Jules Verne University, University hospital of Amiens, 80054 Amiens, France;

关键词: rheumatoid arthritis;    osteoporosis;    fragility fractures;    BMD;    bone remodeling markers;   

DOI  :  10.3390/jcm9103361

来源: DOAJ

【 摘 要 】

Rheumatoid arthritis (RA) is often characterized by bone loss and fragility fractures and is a frequent comorbidity. Compared with a matched population, RA patients with fractures have more common risk factors of osteoporosis and fragility fractures but also risk factors resulting from the disease itself such as duration, intensity of the inflammation and disability, and cachexia. The inflammatory reaction in the synovium results in the production of numerous cytokines (interleukin-1, interleukin-6, tumor necrosis factor) that activate osteoclasts and mediate cartilage and bone destruction of the joints, but also have a systemic effect leading to generalized bone loss. Regular bone mineral density (BMD) measurement, fracture risk assessment using tools such as the FRAX algorithm, and vertebral fracture assessment (VFA) should be performed for early detection of osteoporosis and accurate treatment in RA patients.

【 授权许可】

Unknown